the core of our corporate values
The Drug-Coated PTA Balloon Catheter, a versatile and effective PAD treatment option, features unique Coating Technology and is available on the 0.014”, 0.018” and 0.035” balloon catheter platforms.
A carrrier or an excipient is not always necessary
The DCB drug dose of paclitaxel is 3μg/mm².
UltraFree™ Coating Technology effectively controls paclitaxel crystallization process, resulting in a uniform and stable microcrystal drug coating.
Particle size distribution test results show that 75% of the particles related are in 5-10μm range.
The integrated UltraFree™ coating prevents the early drug flaking during the procedure preparation and the device tracking.
UltraFree™ Coating quickly disintegrates into microcrystalline particles at the lesion site and allows rapid drug transfer to the arterial wall.
The effective drug tissue concentration at the lesion site lasts for more than 90 days.
More options with the clinically proven platforms
|Catheter Tip||Flexible, short and cone-shaped|
|Fold||Three / six folds|
|Balloon Size||Diameter:4.0~12.0mm; Length:20~220mm|
|Usable Length||110cm and 130cm|
The ZENFLUXION™ Drug-coated PTA Balloon Catheters are indicated for Percutaneous Transluminal Angioplasty (PTA) of stenosis or occlusion lesions in iliac, femoral or popliteal arteries.